Legal Representation
Attorney
Ashly I. Boesche
USPTO Deadlines
Next Deadline
758 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-08-31)
Due Date
August 31, 2027
Grace Period Ends
February 29, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 31, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jul 26, 2021 | DP1B | I | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | Loading... |
| Jul 26, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jul 9, 2021 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED | Loading... |
| Jul 9, 2021 | D1BR | I | TEAS DELETE 1(B) BASIS RECEIVED | Loading... |
| Jun 29, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 4, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 4, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 14, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 1, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 22, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 22, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 18, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Dec 16, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 3, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 3, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 3, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 2, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 5, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 28, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Diagnostic reagents, nucleic acids, all for scientific and research use in the field of SARS-CoV-2 or COVID-19
Class 005
Diagnostic reagents, nucleic acids, all for medical diagnostic use in the field of SARS-CoV-2 or COVID-19
Class 010
Medical diagnostic analyzers in the field of SARS-CoV-2 or COVID-19
Class 044
Medical diagnostic testing services in the field of SARS-CoV-2 or COVID-19
Additional Information
Pseudo Mark
PROCLEIX ULTRIO SARS-COV-TWO
Classification
International Classes
001
005
010
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"SARS-COV-2"